Company Filing History:
Years Active: 1994
Title: Angela Siegling: Innovator in Pharmaceutical Chemistry
Introduction
Angela Siegling is a notable inventor based in Weissbach, Germany. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative work on quinazoline compounds. Her dedication to research and development has led to advancements that may benefit various medical applications.
Latest Patents
Angela Siegling holds a patent for a compound known as 3-(mercaptoalkyl)quinazoline. This compound or its tautomer is defined by Formula I, where R¹ can be hydrogen, a 6-methyl, 6-fluoro, 6-chloro, 6-bromo, or 6,7-dimethoxy residue. This patent showcases her expertise in creating novel chemical structures that could have therapeutic potential.
Career Highlights
Angela is currently employed at Arzneimittelerk Dresden GmbH, where she continues to push the boundaries of pharmaceutical research. Her work has not only contributed to her personal achievements but has also enhanced the capabilities of her organization in developing new medicinal products.
Collaborations
Angela has collaborated with esteemed colleagues such as Siegfried Leistner and Michael Gutschow. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas within the field.
Conclusion
Angela Siegling's contributions to pharmaceutical chemistry exemplify the impact of dedicated research and innovation. Her work on quinazoline compounds highlights her role as a leading inventor in her field.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.